Dubai, Dec 24: India will play all their matches of the Champions Trophy in Dubai with the marquee clash against arch-rivals Pakistan scheduled on February 23, the International Cricket Council (ICC) announced on Tuesday.

PTI had reported last week that India will play all their matches in Dubai including the semifinal and final if they qualify.

As has been the case with ICC events, India and Pakistan have been clubbed in the same group which also have New Zealand and Bangladesh.

Group B comprises South Africa, Australia, Afghanistan and England.

The tournament opener will be played in Karachi on February 19 when hosts Pakistan face New Zealand and the final is scheduled for March 9. The premier 50-over event, last played in 2017, will have 15 matches with at least 10 games scheduled in Pakistan.

Rawalpindi, Lahore, and Karachi will be the three hosting venues in Pakistan with the second semifinal to be staged at the refurbished Gaddafi Stadium in Lahore.

"Lahore will also host the final on 9 March, unless India qualify, in which case it will be played in Dubai. Both the semi-finals and the final will have reserve days," said the ICC in a statement.

India will open their campaign against Bangladesh on February 20 before taking on Pakistan three days later. Their final league fixture will be against New Zealand on March 2.

Group B action begins on February 21 when Afghanistan square up against South Africa in Karachi.

A big weekend then kicks off with rivals England and Australia clashing in Lahore on February 22.

The eight sides in the Champions Trophy are the teams that finished in the top eight in the points table at ODI World Cup in India last year.

The ICC has kept reserve days for both the semifinals and the final.

The schedule was announced after a deadlock over the hosting of the tournament ended with the ICC keeping India's games at a neutral venue as desired while having a similar arrangement for Pakistan for ICC events in India till 2027.

The hybrid arrangement will also apply to the 2025 women's ODI World Cup in India and the T20 World Cup in 2026 in India and Sri Lanka.

India had refused to travel to Pakistan for the event due to security concerns. The Indians have not played in Pakistan since the 2008 Mumbai terror attacks in which 150 people were killed.

The two countries' last bilateral engagement was back in 2012. Travelling to Pakistan also requires Indian government's clearance, which has remained firm on the status quo.

While the BCCI's stance was always clear, the matter got stretched because of the PCB's refusal to allow a "one-sided" arrangement of neutral venues.

PCB, which had sent its team to India for the ODI World Cup last year, had categorically opposed the hybrid model but eventually agreed to it on reciprocal grounds.

Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.



Bengaluru (PTI): Karnataka's BioEconomy has reached USD 39.2 billion in 2025, marking strong growth from previous years and reaffirming the state's leadership position nationally, according to an official report released on Monday.

The Karnataka Innovation and Technology Society (KITS), under the Department of Electronics, IT, Biotechnology and Science & Technology, unveiled the Karnataka BioEconomy Report 2025 in collaboration with the Association of Biotechnology Led Enterprises.

The report that was released by IT Minister Priyank Kharge stated that the state contributes around 21 per cent of India's BioEconomy and accounts for over 10 per cent of Karnataka's GSDP.

ALSO READ:  Ethnographic study suggests political, economic support measures for Nadaf, Pinjara communities

According to the report, the BioEconomy has expanded from USD 31.0 billion in 2023, reflecting 26.5 per cent cumulative growth, and is now adding nearly USD 10 billion every quarter to the state's GDP.

BioPharma remains the anchor with over 40 per cent share (about USD 16.44 billion), driven by biologics, biosimilars, vaccines and diagnostics, it said.

"BioIndustrial biotechnology has emerged as the fastest-growing segment (about USD 11.46 billion, around 29 per cent share), led by fermentation-based industries, biofuels, enzymes and sustainable materials," the report stated.

BioServices accounts for about 25.8 per cent share, while BioAgri contributes to sustainable agriculture and input innovation, it added.

The report said BioEconomy growth is becoming increasingly multi-regional. While Bengaluru Urban accounts for about 54 per cent of the state's BioEconomy, Mysuru contributes around 8.7 per cent, while Belagavi and Dakshina Kannada together account for over 9 per cent. Northern districts remain the Agri-biotechnology belt.

As many as 218 new biotech startups were added in 2025, taking the cumulative total to 1,451 startups, with over 75 per cent focused on life sciences and health-tech. Bengaluru accounts for about 54 per cent of startups, it stated.

Between January 2024 and October 2025, the report stated that Karnataka attracted USD 1.14 billion across around 40 deals spanning BioPharma, MedTech, precision fermentation, digital health and AgriBio.

Minister Kharge said, "With our BioEconomy crossing USD 39 billion and contributing over 10 per cent to our GSDP, biotechnology is no longer confined to laboratories - it is now a central driver of economic growth, industrial innovation and societal impact."

He said that the state government's focus is on building a full-spectrum biomanufacturing economy by supporting deep-tech startups, strengthening innovation infrastructure, and ensuring that growth reaches beyond Bengaluru to every region of the state.